Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Federal agencies blame Democrats for looming shutdown in apparent Hatch Act violation

Housing and VA departments attack ‘radical left’ despite law limiting political activities of government employees

The Guardian - US · Sep 30, 2025

Can Americans Trust RFK Jr.'s Health Advice? A Breakdown on Vaccines, Autism, Food Dyes, and More

As ever, be cautious about what you hear from the Department of Health and Human Services.

Reason · Sep 30, 2025

Woman’s ‘Kybella’ Face Transformation Stuns People After Her Extreme Recovery Phase Goes Viral

Bored Panda contacted four dermatologists and plastic surgeons to find out more about Kybella, the FDA-approved treatment that targets the stubborn "double chin."

Bored Panda · Sep 30, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Here are some effects of a government shutdown if Congress, Trump don't reach a deal

The U.S. government is nearing a partial shutdown, with a range of effects on public services and the broader economy

The Independent UK · Sep 30, 2025

2 Penny Stocks That Wall Street Believes Can Soar Over 200%

Penny stocks are highly volatile, but some of them have the potential to deliver outsized returns.

Barchart · Sep 30, 2025

RFK Jr. orders abortion pill ‘safety review’ based on junk science – just like his Tylenol autism claims

Guess which conservative think tank supplied the "evidence" for this one...

We Got This Covered · Sep 30, 2025

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

Benzinga · Sep 29, 2025

Read news from The Economist, FT, and more,
with one subscription

The abortion pill is safe. But why should Trump let facts get in the way?

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

The Guardian - US · Sep 29, 2025

Pfizer sued in US over contraceptive that women say caused brain tumours

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

The Guardian - UK · Sep 28, 2025

3 Healthcare Stocks Using AI to Drive Growth

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

MarketBeat · Sep 27, 2025

9 Warning Signs a Restaurant Won’t Last Due to Bad Service

A great menu can’t save a place that treats guests poorly. Service sets the tone, protects margins, and builds repeat visits. When it’s bad, costs rise, reviews crash, and regulars vanish. You notice it fast: long waits, missing items, mixed-up bills. If you care about your time and money, spotting…

Grocery Coupon Guide · Sep 27, 2025

‘Anti-expert crusade’: what Trump’s hollowing out of US health institutions means for Australia

The impact of Robert F Kennedy Jr on US health organisations will affect research funding and access to medicines but may force Australia to step up, say experts

The Guardian - AU · Sep 27, 2025

What is cesium 137? FDA detects radioactive contamination in second product

Federal regulators have detected possible radioactive contamination in spices exported from Indonesia

The Independent UK · Sep 26, 2025

What is leucovorin, the drug the FDA approved to treat autism?

This week the FDA approved the generic drug as a treatment for autism – a move that shocked health experts

The Guardian - US · Sep 26, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Sep 26, 2025

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that could determine whether affected women can pursue their cases in court.

Benzinga · Sep 26, 2025

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Benzinga · Sep 26, 2025

FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder

On Thursday, the U.S. Food and Drug Administration (FDA) approved Crinetics Pharmaceuticals, Inc.’s (NASDAQ: CRNX) Palsonify (paltusotine) for the first-line treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.

Benzinga · Sep 26, 2025

Why Is Organogenesis Stock Trading Lower Friday?

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for the management of symptoms associated with knee osteoarthritis (OA).

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Sep 26, 2025

FDA Expands Use Of Regeneron's Evkeeza To Infants With Rare Cholesterol Disorder

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals, Inc.’s (NASDAQ: REGN) Evkeeza (evinacumab-dgnb) ANGPTL3 antibody as an adjunct to diet and exercise and other lipid-lowering therapies for the treatment of children from age 1 to less than 5 years old with homozygous familial hypercholesterolemia (HoFH).

Benzinga · Sep 26, 2025

Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.

Benzinga · Sep 26, 2025

FDA Approves Eli Lilly's Drug For Advanced Breast Cancer

On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE: LLY) Inluriyo (imlunestrant) for adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after at least one line of endocrine therapy (ET).

Benzinga · Sep 26, 2025

Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company developing non-opioid, non-IV sedation therapies for hospitals and outpatient care.

Axios · Sep 26, 2025

RFK Jr. sets off new abortion alarms with latest move

The Trump administration is facing conflicting political pressures over Kennedy's recent move.

Benzinga · Sep 25, 2025

Biogen Faces FDA Setback On High-Dose Nusinersen Filing For Spinal Muscular Atrophy

On Tuesday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for Biogen Inc.’s (NASDAQ: BIIB) supplemental New Drug Application (sNDA) for the high-dose regimen of nusinersen for the treatment of spinal muscular atrophy (SMA).

Benzinga · Sep 25, 2025

Why Capricor Therapeutics Stock Is Surging Today

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are up Thursday after the company announced progress regarding one of its rare disease therapeutics. The biotech company’s stock jumped 18% immediately following the news.

1 … 96 97 98 99

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

National Institutes of Health

278 stories

HUD

275 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.